U.S., Nov. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07247084) titled 'A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)' on Nov. 19.
Brief Summary: The purpose of this study is to evaluate tirzepatide within a real-world setting to assess body weight loss and incidence of type 2 diabetes in adults without diabetes who have obesity and at least one weight-related comorbid condition. Participation in the study will last about 260 weeks.
Study Start Date: Dec., 2025
Study Type: INTERVENTIONAL
Condition:
Obesity
Intervention:
DRUG: Tirzepatide
Administered SC
OTHER: Standard of Care
Standard of care
Recrui...